Top Markets
Coin of the day
Scilex Holding Company Scilex Holding Company

Scilex Holding Company

SCLX
Rang in aandelen #25626
Scilex Holding Company is a biopharmaceutical enterprise that specializes in... Scilex Holding Company is a biopharmaceutical enterprise that specializes in the development and market introduction of non-opioid therapies designed to alleviate both acute and chronic pain. Its primary marketed offering is ZTlido 1.8%, a topical prescription formulation of lidocaine specifically engineered to mitigate neuropathic discomfort associated with post-herpetic neuralgia, a condition characterized by persistent nerve pain following shingles. Beyond this, the company's development pipeline includes SP-102, a viscous gel corticosteroid for epidural administration, currently undergoing Phase III trials for lumbosacral radicular pain. Another candidate, SP-103, is progressing through Phase II trials for managing low back pain. Furthermore, SP-104, a novel, low-dose, delayed-release naltrexone hydrochloride formulation, has successfully concluded Phase I clinical testing for the treatment of fibromyalgia. Its corporate offices are situated in Palo Alto, California. Scilex Holding Company operates as a subsidiary of Sorrento Therapeutics, Inc.
Aandeelprijs
$5.61
Laatst gesynchroniseerd: 2026-08-20
Marktkapitalisatie
$47.65M
Verandering (1 dag)
-0.68%
Verandering (1 jaar)
-67.26%
Land
US
Handel Scilex Holding Company (SCLX)

Categorie

Koersgeschiedenis voor Scilex Holding Company (SCLX)
Hoogste slotkoers: $6.52 op 2026-08-01

Laagste slotkoers: $346.22 op 2021-03-01
Koersgeschiedenis van Scilex Holding Company van 2021 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2026 (TTM) -26.12%
2025 -11.79%
2024 -61.32%
2023 -63.10%
2022 -63.74%
2021 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
$1.25K 75.69%
US
$268.08 49.82%
US
$262.00 25.06%
US
$489.01 44.10%
CH
$149.16 73.28%
US